B-amyloid as a Marker for GBM Bioimaging
NCT05820191
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
3
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma
Interventions
DRUG:
Amyvid, Intravenous Solution
Sponsor
Universidad Central del Caribe
Collaborators
[object Object]